Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people's Republic of China.

Abstract	The reported number of registered leprosy patients worldwide declined with the introduction of multidrug therapy. However, the emergence of rifampicin resistance in leprosy patients engenders difficulties for an individual patient, and its dissemination could pose a threat to leprosy control. This study reports an elderly patient who was diagnosed with rifampicin-resistant lepromatous leprosy. This case indicates that inadequate treatment and poor compliance may eventually result in rifampicin resistance in Mycobacterium leprae and clinical relapse.
Authors	Meiwen Yu, Kan Wu, Bing Pei, Degang Yang, Qiulin Wang, Hongsheng Wang, Jianping Shen, Liangbing Yan, Guochen Zhang
Journal	Clinical interventions in aging (Clin Interv Aging) Vol. 8 Pg. 1097-9 ( 2013) ISSN: 1178-1998 [Electronic] New Zealand
PMID	23986632 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Leprostatic Agents Rifampin
Topics	Aged Drug Resistance, Microbial (drug effects) Humans Leprostatic Agents (therapeutic use) Leprosy, Lepromatous (drug therapy) Male Medication Adherence Mycobacterium leprae (drug effects) Rifampin (therapeutic use) Taiwan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!